¼¼°èÀÇ ½Ç½Ã°£ PCR, µðÁöÅÐ PCR ¹× ¿£µåÆ÷ÀÎÆ® PCR ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)
Global Real-time PCR, Digital PCR, And End-point PCR Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
»óǰÄÚµå : 1448760
¸®¼­Ä¡»ç : Value Market Research
¹ßÇàÀÏ : 2024³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 292 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,920 £Ü 5,517,000
PDF & Excel (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,730 £Ü 6,657,000
PDF & Excel (10-user License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,430 £Ü 10,457,000
PDF & Excel (Corporate User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ½Ç½Ã°£ PCR, µðÁöÅÐ PCR ¹× ¿£µåÆ÷ÀÎÆ® PCR ½ÃÀå ¼ö¿ä´Â 2023³â 81¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2032³â¿¡´Â ¾à 128¾ï 1,000¸¸ ´Þ·¯ ½ÃÀå ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, Á¶»ç ±â°£ 2024³âºÎÅÍ 2032³â±îÁö CAGRÀº 5.14%·Î Àü¸ÁµË´Ï´Ù.

ÁßÇÕÈ¿¼Ò ¿¬¼â¹ÝÀÀ(PCR)Àº DNAÀÇ ÁõÆø°ú ºÐ¼®¿¡ »ç¿ëµÇ´Â ºÐÀÚ »ý¹°ÇÐ ±â¼úÀÔ´Ï´Ù. PCR¿¡´Â ½Ç½Ã°£ PCR, µðÁöÅÐ PCR ¹× ¿£µåÆ÷ÀÎÆ® PCR µî ¿©·¯ °¡Áö º¯ÇüÀÌ ÀÖÀ¸¸ç, °¢°¢ ¿ëµµ¿Í ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

PCR ±â¼ú¿¡ ´ëÇÑ ¼¼°è ¼ö¿ä´Â COVID-19 °Ë»ç¿¡¼­ÀÇ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒ ¶§¹®¿¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÆÒµ¥¹ÍÀº SARS-CoV-2 ¹ÙÀÌ·¯½ºÀÇ À¯Àü ¹°ÁúÀÇ °ËÃâ¿¡ À־ ±× Á߿伺À» ºÎ°¢½ÃÄ×½À´Ï´Ù. °¨¿°Áõ Áø´Ü¿¡ ±¹ÇѵÇÁö ¾Ê°í PCRÀº ºÐÀÚÁø´ÜÀÇ ÇÙ½ÉÀÌ¸ç ±× È®Àå¿¡ ±â¿©ÇÕ´Ï´Ù. »ý¸í°úÇÐ ¿¬±¸, ƯÈ÷ À¯ÀüüÇÐ¿Í ´Ü¹éÁúüÇÐÀÇ Áøº¸°¡ ÀÌ ±â¼ú ¼ö¿ä¸¦ ´õ¿í ³ôÀ̰í ÀÖ½À´Ï´Ù. À¯Àü ÁúȯÀÇ Áõ·Ê Áõ°¡ ¹× Á¤È®ÇÑ Á¶±â Áø´ÜÀÇ Çʿ伺Àº À¯Àü °Ë»ç¿¡¼­ PCR ±â¹Ý Á¢±Ù¹ýÀÇ Ã¤ÅÃÀ» µÞ¹ÞħÇÕ´Ï´Ù. ½Ç½Ã°£ PCR°ú µðÁöÅÐ PCRÀ» Æ÷ÇÔÇÑ Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀüÀº DNA ÁõÆøÀÇ È¿À²¼º°ú °¨µµ¸¦ ³ôÀÌ°í ½ÃÀå ¼ºÀåÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î °Ë»ç ¼Ö·ç¼Ç ¼ö¿ä ¹× ½Å¼Ó Áø´Ü¿¡ ÈÞ´ë¿ë PCR ±â¼úÀÇ ÀÀ¿ëÀÌ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Á¦¾à ¹× »ý¸í°øÇÐ »ê¾÷¿¡¼­ PCRÀº ÀǾàǰ °³¹ß, ¹ß°ß, ǰÁú °ü¸®¿¡ ÇʼöÀûÀÌ¸ç ½ÃÀåÀÇ Á¸Àç°¨À» ´õ¿í ³ô¿©ÁÖ°í ÀÖ½À´Ï´Ù. PCRÀÌ °è¼Ó ÁøÈ­ÇÏ°í ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ ÀÀ¿ëµÊ¿¡ µû¶ó ½ÃÀå ¼ºÀåÀº Áö¼ÓµÇ°í Áø´Ü ¹× ¿¬±¸ ¿ä±¸ÀÇ º¯È­¿¡ ÀûÀÀÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Â ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ì´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í °æÀïÀÇ ¸Å·ÂÀ» ¼¼°è ¼öÁØ¿¡¼­ Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â ¼¼°èÀÇ ½Ç½Ã°£ PCR, µðÁöÅÐ PCR ¹× ¿£µåÆ÷ÀÎÆ® PCR ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½Ç½Ã°£ PCR, µðÁöÅÐ PCR ¹× ¿£µåÆ÷ÀÎÆ® PCR »ê¾÷ÀÇ ¼ºÀå ¹× µ¿ÇâÀº º» ¿¬±¸¿¡ Àü¹ÝÀûÀÎ Á¢±Ù¹ýÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

½Ç½Ã°£ PCR, µðÁöÅÐ PCR ¹× ¿£µåÆ÷ÀÎÆ® PCR ½ÃÀå º¸°í¼­ÀÇ ÀÌ ¼½¼Ç¿¡¼­´Â ±¹°¡ ¹× Áö¿ª ¼öÁØÀÇ ºÎ¹®¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇϹǷΠÀü·« ´ã´çÀÚ°¡ ÇâÈÄ ºñÁî´Ï½º ±âȸ¿Í °¢ Á¦Ç° ¶Ç´Â ¼­ºñ½ºÀÇ ´ë»ó °èÃþÀ» È®ÀÎÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

±â¼úº°

Á¦Ç°º°

¿ëµµ À¯Çüº°

Áö¿ª ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­ ½Ç½Ã°£ PCR, µðÁöÅÐ PCR ¹× ¿£µåÆ÷ÀÎÆ® PCR ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ ÀÌ º¸°í¼­´Â ¸ðµç ÁÖ¿ä Áö¿ª¿¡¼­ °³º° ¿ëµµ ºÎ¹® ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÁßÁ¡À» µÓ´Ï´Ù.

¸ÂÃ㠿䱸»çÇ×ÀÌ ÀÖÀ¸¸é, ÀúÈñ¿¡°Ô ¿¬¶ôÇØ ÁÖ¼¼¿ä. ´ç»çÀÇ ¼³¹®Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½Ç½Ã°£ PCR, µðÁöÅÐ PCR ¹× ¿£µåÆ÷ÀÎÆ® PCR-»ê¾÷ ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ ½Ç½Ã°£ PCR, µðÁöÅÐ PCR ¹× ¿£µåÆ÷ÀÎÆ® PCR ½ÃÀå ºÐ¼® : ±â¼úº°

Á¦6Àå ¼¼°èÀÇ ½Ç½Ã°£ PCR, µðÁöÅÐ PCR ¹× ¿£µåÆ÷ÀÎÆ® PCR ½ÃÀå ºÐ¼® : Á¦Ç°º°

Á¦7Àå ¼¼°èÀÇ ½Ç½Ã°£ PCR, µðÁöÅÐ PCR ¹× ¿£µåÆ÷ÀÎÆ® PCR ½ÃÀå ºÐ¼® : ¿ëµµ À¯Çüº°

Á¦8Àå ¼¼°èÀÇ ½Ç½Ã°£ PCR, µðÁöÅÐ PCR ¹× ¿£µåÆ÷ÀÎÆ® PCR ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦9Àå ½Ç½Ã°£ PCR, µðÁöÅÐ PCR ¹× ¿£µåÆ÷ÀÎÆ® PCR ±â¾÷ °æÀï ±¸µµ

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global demand for Real-time PCR, Digital PCR, And End-point PCR Market is presumed to reach the market size of nearly USD 12.81 BN by 2032 from USD 8.16 BN in 2023 with a CAGR of 5.14% under the study period 2024 - 2032.

Polymerase Chain Reaction (PCR) is a molecular biology technique used to amplify and analyze DNA. There are several variations of PCR, including real-time PCR, digital PCR, and endpoint PCR, each with its own applications and advantages.

MARKET DYNAMICS

The global demand for PCR technology has surged due to its pivotal role in COVID-19 testing. The pandemic has highlighted its importance in detecting the genetic material of the SARS-CoV-2 virus. Beyond infectious disease diagnostics, PCR remains a cornerstone in molecular diagnostics, contributing to its expansion. Advances in life sciences research, particularly in genomics and proteomics, further fuel the demand for this technology. The rising cases of genetic disorders and the need for precise and early diagnosis propel the adoption of PCR-based methods in genetic testing. Continuous technological advancements, including real-time PCR and digital PCR, enhance the efficiency and sensitivity of DNA amplification, reinforcing market growth. Additionally, the demand for point-of-care testing solutions and the application of portable PCR technologies in rapid diagnostics contribute to the market's expansion. In the pharmaceutical and biotechnology industries, PCR is integral for drug development, discovery, and quality control, further driving its market presence. As PCR continues to evolve and find applications across diverse sectors, its market growth is expected to persist, adapting to the changing landscape of diagnostic and research needs.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of real-time pcr, digital pcr, and end-point pcr. The growth and trends of real-time pcr, digital pcr, and end-point pcr industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the real-time pcr, digital pcr, and end-point pcr market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

By Product

By Application Type

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Real-time PCR, Digital PCR, And End-point PCR market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Real-time PCR, Digital PCR, And End-point PCR market include Abbott, Qiagen, Bio-Rad Laboratories Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., GE Healthcare, bioMerieux, F. Hoffmann-La Roche Ltd, Fluidigm Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

2 . EXECUTIVE SUMMARY

3 . REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR - INDUSTRY ANALYSIS

4 . VALUE CHAIN ANALYSIS

5 . GLOBAL REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR MARKET ANALYSIS BY TECHNOLOGY

6 . GLOBAL REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR MARKET ANALYSIS BY PRODUCT

7 . GLOBAL REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR MARKET ANALYSIS BY APPLICATION TYPE

8 . GLOBAL REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR MARKET ANALYSIS BY GEOGRAPHY

9 . COMPETITIVE LANDSCAPE OF THE REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR COMPANIES

10 . COMPANY PROFILES OF REAL-TIME PCR, DIGITAL PCR, AND END-POINT PCR INDUSTRY

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â